U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509957) titled 'Effect of Preoperative Erector Spinae Plane Block on Recovery Quality, Time to Return to Da... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510347) titled 'Perioperative Analgesic Effect of Different Volumes of Modified Thoracoabdominal Perichondr... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509801) titled 'A Study to Evaluate the Safety and Efficacy of NT-88' on March 24. Brief Summary: A study ... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510633) titled 'A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Ove... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509762) titled 'Exercise Programs in Women With PCOS' on March 24. Brief Summary: This study aims to inves... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509710) titled 'Dynamic Postoperative Trends for Early Detection of Complications After Gastrointestinal Su... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510386) titled 'CGM After Discharge From Hospital' on March 30. Brief Summary: This is an investigator ini... Read More
U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510191) titled 'TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal ... Read More
Singapore, April 4 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 4 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More